,outcome,arm 1,arm 2
0,intervention,pioglitazone group,glimepiride group
0,"after 52 weeks, HbA ( 1c ) values",7.46 %,7.77 %
0,"HbA ( 1c ) values, after 12 weeks of therapy",8.66 %,7.80 %
